PRECIGEN, INC. Operating Leases, Income Statement, Sublease Revenue
PRECIGEN, INC. (PGEN) reported Operating Leases, Income Statement, Sublease Revenue of $137.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue · last filed 2018-03-01
- PRECIGEN, INC. operating leases, income statement, sublease revenue for the quarter ending 2017-12-31 was $32.00K, a 83.76% decline year-over-year.
- PRECIGEN, INC. operating leases, income statement, sublease revenue for the quarter ending 2017-09-30 was $32.00K, a 82.61% decline year-over-year.
- PRECIGEN, INC. operating leases, income statement, sublease revenue for the quarter ending 2017-06-30 was $34.00K, a 89.85% decline year-over-year.
- PRECIGEN, INC. operating leases, income statement, sublease revenue for the quarter ending 2017-03-31 was $41.00K, a 87.76% decline year-over-year.
- PRECIGEN, INC. operating leases, income statement, sublease revenue for fiscal 2017 was $137.00K, a 86.96% decline from fiscal 2016.
- PRECIGEN, INC. operating leases, income statement, sublease revenue for fiscal 2016 was $1.05M, a 29.27% decline from fiscal 2015.
- PRECIGEN, INC. operating leases, income statement, sublease revenue for fiscal 2015 was $1.49M, a 63.66% increase from fiscal 2014.
- PRECIGEN, INC. operating leases, income statement, sublease revenue for fiscal 2014 was $908.00K, a 148.77% increase from fiscal 2013.
| Period end | Operating Leases, Income Statement, Sublease Revenue 3 month | Operating Leases, Income Statement, Sublease Revenue 3 month as first filed | Operating Leases, Income Statement, Sublease Revenue 6 month | Operating Leases, Income Statement, Sublease Revenue 6 month as first filed | Operating Leases, Income Statement, Sublease Revenue 9 month | Operating Leases, Income Statement, Sublease Revenue 9 month as first filed | Operating Leases, Income Statement, Sublease Revenue 12 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $64.00K derived: sum of 2 quarters · filed 2018-03-01 | $98.00K derived: sum of 3 quarters · filed 2018-03-01 | $137.00K 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $32.00K 10-Q · filed 2017-11-09 | $66.00K derived: sum of 2 quarters · filed 2017-11-09 | $105.00K 10-Q · filed 2017-11-09 | $304.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-06-30 | $34.00K 10-Q · filed 2017-08-09 | $75.00K 10-Q · filed 2017-08-09 | $272.00K derived: sum of 3 quarters · filed 2018-03-01 | $456.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2017-03-31 | $41.00K 10-Q · filed 2017-05-10 | $238.00K derived: sum of 2 quarters · filed 2018-03-01 | $422.00K derived: sum of 3 quarters · filed 2018-03-01 | $757.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $381.00K derived: sum of 2 quarters · filed 2018-03-01 | $716.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.05M 10-K · filed 2018-03-01 | |||
| 2016-09-30 | $184.00K 10-Q · filed 2017-11-09 | $519.00K derived: sum of 2 quarters · filed 2017-11-09 | $854.00K 10-Q · filed 2017-11-09 | $1.19M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $335.00K 10-Q · filed 2017-08-09 | $670.00K 10-Q · filed 2017-08-09 | $1.00M derived: sum of 3 quarters · filed 2018-03-01 | $1.34M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $335.00K 10-Q · filed 2017-05-10 | $668.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.00M derived: sum of 3 quarters · filed 2018-03-01 | $1.40M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $667.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.06M derived: sum of 3 quarters · filed 2018-03-01 | $1.49M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $334.00K 10-Q · filed 2016-11-09 | $728.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.15M 10-Q · filed 2016-11-09 | $1.53M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $394.00K 10-Q · filed 2016-08-09 | $819.00K 10-Q · filed 2016-08-09 | $1.20M derived: sum of 3 quarters · filed 2017-03-01 | $1.47M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $425.00K 10-Q · filed 2016-05-10 | $801.00K derived: sum of 2 quarters · filed 2017-03-01 | $1.07M derived: sum of 3 quarters · filed 2017-03-01 | $1.24M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $646.00K derived: sum of 2 quarters · filed 2017-03-01 | $817.00K derived: sum of 3 quarters · filed 2017-03-01 | $908.00K 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $270.00K 10-Q · filed 2015-11-09 | $441.00K derived: sum of 2 quarters · filed 2015-11-09 | $532.00K 10-Q · filed 2015-11-09 | $624.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $171.00K 10-Q · filed 2015-08-10 | $262.00K 10-Q · filed 2015-08-10 | $354.00K derived: sum of 3 quarters · filed 2016-02-29 | $445.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $91.00K 10-Q · filed 2015-05-11 | $183.00K derived: sum of 2 quarters · filed 2016-02-29 | $274.00K derived: sum of 3 quarters · filed 2016-02-29 | $365.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $183.00K derived: sum of 2 quarters · filed 2016-02-29 | $274.00K derived: sum of 3 quarters · filed 2016-02-29 | $365.00K 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $91.00K 10-Q · filed 2014-11-13 | $182.00K derived: sum of 2 quarters · filed 2014-08-14 | $273.00K 10-Q · filed 2014-11-13 | $274.00K 10-Q · filed 2013-11-07 | $360.00K derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $91.00K 10-Q · filed 2014-08-14 | $92.00K 10-Q/A · filed 2013-10-21 | $182.00K 10-Q · filed 2014-08-14 | $183.00K 10-Q/A · filed 2013-10-21 | $269.00K derived: sum of 3 quarters · filed 2015-03-02 | $269.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $91.00K 10-Q · filed 2014-05-09 | $178.00K derived: sum of 2 quarters · filed 2015-03-02 | $178.00K derived: sum of 3 quarters · filed 2015-03-02 | $188.00K derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $87.00K derived: sum of 2 quarters · filed 2015-03-02 | $97.00K derived: sum of 3 quarters · filed 2015-03-02 | $151.00K 10-K · filed 2015-03-02 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-07 | $10.00K derived: sum of 2 quarters · filed 2013-11-07 | $64.00K 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $10.00K 10-Q/A · filed 2013-10-21 | $64.00K 10-Q/A · filed 2013-10-21 | |||||
| 2011-12-31 | $158.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |